questions following the destiny-breast trials
Published 7 months ago • 97 plays • Length 2:26Download video MP4
Download video MP3
Similar videos
-
5:02
reflections on the destiny-breast04 trial | patricia lorusso
-
12:19
sabcs 2022: updated survival results of the randomized, phase 3 study destiny-breast03 q & a
-
1:32
destiny-breast15: t-dxd in patients with hr hr- and her2-low or her2 ihc 0 metastatic breast cancer
-
33:41
clinical trials for metastatic breast cancer: what you should know | dana-farber cancer institute
-
1:33
questions remaining in the field of her2-low breast cancer
-
1:34:18
breast cancer trials q&a - breast cancer recurrence
-
4:35
a new way of detecting and monitoring cancer by measuring ctdna - dr tasha
-
3:04
head and neck cancer at asco 2022
-
1:40
unanswered questions in breast cancer
-
11:35
sabcs 2022: primary results of the randomized, phase 3 study destiny-breast02 q & a
-
1:15
evaluating trastuzumab deruxtecan in earlier lines of breast cancer therapy
-
1:43
dr hamilton on implications of destiny-breast06 on the her2-low breast cancer paradigm
-
1:57
impact of cdk4/6 inhibitors on hr-positive, her2-negative advanced breast cancer
-
1:11
the mimosa trial and a novel prognostic factor in breast cancer
-
58:37
finding clinical trials for metastatic breast cancer
-
2:11
the use of frontline cdk4/6 inhibitors endocrine therapy in metastatic breast cancer
-
1:29
the predictive value of treatment response after neoadjuvant therapy
-
1:25:11
breast cancer trials q&a: metastatic breast cancer
-
0:36
maintenance w/ et ribociclib after 1l chemotherapy in hr /her2- metastatic breast cancer
-
4:52
3-year dfs in randomized trials of chemotherapy and her2-targeted therapy
-
3:29
designing innovative clinical trials in bc
-
0:58
comparing and sequencing t-dm1 and t-dxd in her2 breast cancer